Search - tctmd.com

Displaying 1 - 20 of 112

Sort: Relevancy | Date

News Daily News

Revascularization Decisions in the Elderly Require a Holistic Approach: AHA

Caitlin E. Cox

November 24, 2025

News Conference News AHA 2025

Lower Mortality With Complete Revascularization in Acute MI Patients With MVD

Michael O'Riordan

November 12, 2025

News Conference News TCT 2025

Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions

Todd Neale

October 26, 2025

News Conference News EuroPCR 2025

IVL Effective in Severely Calcified Lesions, Especially in Women

Yael L. Maxwell

May 22, 2025

News Daily News

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Michael O'Riordan

March 26, 2025

News Conference News TCT 2024

DCB Outdo Noncompliant Balloons in Simple Bifurcation Side Branches: DCB-BIF

Caitlin E. Cox

October 28, 2024

News Daily News

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Michael O'Riordan

September 20, 2024

News Conference News ESC 2024

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

Michael O'Riordan

September 01, 2024

News Daily News

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Michael O'Riordan

July 01, 2024

News Daily News

With ANOCA, Better to Test Coronary Function in Multiple Vessels

Caitlin E. Cox

May 29, 2024

News Conference News EuroPCR 2024

ORBITA-2: Angina Phenotype Strongly Predicts PCI Response

Caitlin E. Cox

May 15, 2024

News Conference News ACC 2024

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

L.A. McKeown

April 08, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Daily News

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

Todd Neale

March 04, 2024

News Daily News

Even After Multivessel or LM PCI, Routine Stress Testing Adds Nothing

Yael L. Maxwell

March 01, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

CTO Diagnosed, Now What? European Experts Offer Advice on Revascularization

Caitlin E. Cox

February 09, 2024

News Daily News

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Michael O'Riordan

January 30, 2024

News Daily News

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Michael O'Riordan

December 27, 2023

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

Advertisement

Revascularization Decisions in the Elderly Require a Holistic Approach: AHA

Lower Mortality With Complete Revascularization in Acute MI Patients With MVD

Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions

IVL Effective in Severely Calcified Lesions, Especially in Women

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

DCB Outdo Noncompliant Balloons in Simple Bifurcation Side Branches: DCB-BIF

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

With ANOCA, Better to Test Coronary Function in Multiple Vessels

ORBITA-2: Angina Phenotype Strongly Predicts PCI Response

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

Even After Multivessel or LM PCI, Routine Stress Testing Adds Nothing

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

CTO Diagnosed, Now What? European Experts Offer Advice on Revascularization

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Top Coronary Artery Disease News of 2023

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content